Global Patient Registry Software Market, By Type (Disease Registries, Health Service Registries, Product Registries), Software (Standalone, Integrated), Pricing Model (Subscription, Ownership), Deployment Model (On-Premise, Cloud-Based), Database (Commercial, Public), Functionality (PHM, Patient Care Management, Health Information Exchange, Point-of-Care, Product Outcome Evaluation, Medical Research & Clinical Studies), End Use (Government Organizations & Third-Party Administrators, Hospitals and Medical Practices, Private Payers, Pharmaceutical, Biotechnology, and Medical Device Companies, Research Centers), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029